Butterfly Medical
Butterfly Medical has developed a fast, non-invasive alternative treatment to first-line benign prostate hyperplasia medication & surgery.
Butterfly Medical has raised €5.9M across 1 funding round from 1 investor, most recently a Series B round in Oct 2020. Based in Yoqne`am `illit, Israel; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€5.9M
€5,948,334
Funding rounds
1
Investors
1
distinct backers
Active since
2020-10
latest 2020-10
Funding by year
EUR raised per yearButterfly Medical — funding by year — interactive chart.
Data table
| Butterfly Medical — funding by year | |
|---|---|
| 2020 | €5.9M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-06 | Series B | €5.9M | New Rhein Healthcare | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData